Literature DB >> 2882674

Immediate and long-term pathophysiologic mechanisms underlying the genesis of sudden cardiac death in patients with congestive heart failure.

M Packer, S S Gottlieb, M A Blum.   

Abstract

Congestive heart failure is the most important predisposing factor to the occurrence of sudden death in patients with cardiovascular disease. As left ventricular dysfunction deteriorates and symptoms of heart failure become evident, ambulatory ventricular arrhythmias become increasingly frequent and complex, and sudden cardiac death becomes an increasingly common occurrence. When the left ventricular ejection fraction has declined to less than 30 percent and symptoms of heart failure become refractory to treatment with digitalis and diuretics, 35 to 50 percent of patients will die of a lethal cardiac arrhythmia within three years. A number of factors interact to determine the occurrence of malignant ventricular arrhythmias in patients with congestive heart failure. Myocardial fibrosis and enhanced left ventricular wall stress may alter the electrophysiologic properties of the myocardium, but these factors may not be sufficient to explain the development of lethal rhythm disturbances. Neurohormonal activation may exacerbate the frequency and complexity of ambulatory arrhythmias in these patients, but such activation can persist for long periods without fatal electrophysiologic sequelae. Recent investigations suggest that electrolyte depletion may provide an important immediate precipitating cause for the occurrence of fatal ventricular tachyarrhythmias in the patient with severe left ventricular dysfunction whose susceptibility is markedly heightened by preexisting structural, hemodynamic, or neurohormonal factors. Further work is needed to determine if prophylactic therapy directed at preventing electrolyte depletion can favorably modify the long-term outcome of these severely ill patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2882674     DOI: 10.1016/0002-9343(87)90126-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

Review 1.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

2.  Segmental wall motion abnormalities alter vulnerability to ventricular ectopic beats associated with acute increases in aortic pressure in patients with underlying coronary artery disease.

Authors:  K Siogas; S Pappas; G Graekas; J Goudevenos; G Liapi; D A Sideris
Journal:  Heart       Date:  1998-03       Impact factor: 5.994

Review 3.  Proarrhythmia, a serious complication of antiarrhythmic drugs.

Authors:  P J Podrid
Journal:  Curr Cardiol Rep       Date:  1999-11       Impact factor: 2.931

4.  Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure.

Authors:  Mihai Gheorghiade; James D Flaherty; Gregg C Fonarow; Ravi V Desai; Richard Lee; David McGiffin; Thomas E Love; Inmaculada Aban; Eric J Eichhorn; Robert O Bonow; Ali Ahmed
Journal:  Int J Cardiol       Date:  2010-06-16       Impact factor: 4.164

5.  Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure.

Authors:  Wei Jiang; Christopher O'Connor; Susan G Silva; Maragatha Kuchibhatla; Michael S Cuffe; Dwayne D Callwood; Bosh Zakhary; Elizabeth Henke; Rebekka M Arias; Ranga Krishnan
Journal:  Am Heart J       Date:  2008-07-07       Impact factor: 4.749

Review 6.  Sudden adult death.

Authors:  Neil E I Langlois
Journal:  Forensic Sci Med Pathol       Date:  2009-07-18       Impact factor: 2.007

7.  Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br Heart J       Date:  1991-09

8.  Double blind controlled study of low dose intravenous perindoprilat or enalaprilat infusion in elderly patients with heart failure.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br Heart J       Date:  1993-04

9.  Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.

Authors:  I B Squire; R J Macfadyen; K R Lees; W S Hillis; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1994-08       Impact factor: 4.335

10.  Magnesium and C-reactive protein in heart failure: an anti-inflammatory effect of magnesium administration?

Authors:  Dorit Almoznino-Sarafian; Sylvia Berman; Anat Mor; Miriam Shteinshnaider; Oleg Gorelik; Irma Tzur; Irena Alon; David Modai; Natan Cohen
Journal:  Eur J Nutr       Date:  2007-05-03       Impact factor: 4.865

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.